Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 1 |
| Since 2017 (last 10 years) | 1 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Comparative Analysis | 1 |
| Consortia | 1 |
| Corporations | 1 |
| Data Analysis | 1 |
| Databases | 1 |
| Epidemiology | 1 |
| Financial Support | 1 |
| Intervention | 1 |
| Medical Research | 1 |
| Meta Analysis | 1 |
| Randomized Controlled Trials | 1 |
| More ▼ | |
Source
| Research Synthesis Methods | 1 |
Author
| Abdi, Suhayb | 1 |
| Clayton, Gemma | 1 |
| Gelle, Mustafe Hassan Adan | 1 |
| Hróbjartsson, Asbjørn | 1 |
| Laursen, David Ruben Teindl | 1 |
| Lundh, Andreas | 1 |
| Nejstgaard, Camilla Hansen | 1 |
| Olorisade, Babatunde Kazeem | 1 |
| Savovic, Jelena | 1 |
Publication Type
| Information Analyses | 1 |
| Journal Articles | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkNejstgaard, Camilla Hansen; Lundh, Andreas; Abdi, Suhayb; Clayton, Gemma; Gelle, Mustafe Hassan Adan; Laursen, David Ruben Teindl; Olorisade, Babatunde Kazeem; Savovic, Jelena; Hróbjartsson, Asbjørn – Research Synthesis Methods, 2022
Randomised trials are often funded by commercial companies and methodological studies support a widely held suspicion that commercial funding may influence trial results and conclusions. However, these studies often have a risk of confounding and reporting bias. The risk of confounding is markedly reduced in meta-epidemiological studies that…
Descriptors: Medical Research, Randomized Controlled Trials, Corporations, Financial Support
